Back to Browse Journals » Vascular Health and Risk Management » Volume 5

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

Authors Jacob George, Allan D Struthers

Published 5 March 2009 Volume 2009:5 Pages 265—272


Review by Single-blind

Peer reviewer comments 4

Jacob George, Allan D Struthers

Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK

Abstract: Oxidative stress plays an important role in the progression of vascular endothelial dysfunction. The two major systems generating vascular oxidative stress are the NADPH oxidase and the xanthine oxidase pathways. Allopurinol, a xanthine oxidase inhibitor, has been in clinical use for over 40 years in the treatment of chronic gout. Allopurinol has also been shown to improve endothelial dysfunction, reduce oxidative stress burden and improve myocardial efficiency by reducing oxygen consumption in smaller mechanistic studies involving various cohorts at risk of cardiovascular events. This article aims to explain the role of xanthine oxidase in vascular oxidative stress and to explore the mechanisms by which allopurinol is thought to improve vascular and myocardial indices.

Keywords: allopurinol, vascular oxidative stress, vascular endothelial dysfunction

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

The role of urate and xanthine oxidase in vascular oxidative stress: future directions

Jacob George, Allan Struthers

Therapeutics and Clinical Risk Management 2009, 5:799-803

Published Date: 5 October 2009

Readers of this article also read:

Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report

Park TS, Hong Y, Lee JS, Oh SY, Lee SM, Kim N, Seo JB, Oh YM, Lee SD, Lee SW

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1501-1511

Published Date: 29 July 2015

Red cell distribution width and neurological scoring systems in acute stroke patients

Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA

Neuropsychiatric Disease and Treatment 2015, 11:733-739

Published Date: 18 March 2015

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells

Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A

International Journal of Nanomedicine 2012, 7:1805-1818

Published Date: 3 April 2012

Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence

Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al

Vascular Health and Risk Management 2009, 5:1015-1031

Published Date: 18 November 2009

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy

Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, et al

Vascular Health and Risk Management 2009, 5:801-810

Published Date: 21 September 2009

Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension

Martin Thoenes, Jan-Christian Reil, Bobby Varkey Khan, Peter Bramlage, et al.

Vascular Health and Risk Management 2009, 5:577-585

Published Date: 13 July 2009